Annexon, Inc.
United States
Member Since:Jan 17, 2024
Ownership:N/A
Number of Offices:N/A
Total Employees:N/A
Established In:N/A
We’re passionate about bringing game-changing therapies to patients suffering from serious complement-mediated autoimmune, neurodegenerative and ophthalmic disorders.
CSO, Larry Mattheakis, Ph.D
CFO, Jennifer Lew
Company Ownership: Public
Stock Symbol: ANNX
Stock Exchange: NASDAQ
No record available!
No record available!
No record available!
No record available!
No record available!
No record available!